Table 4.
Change from baseline | Repeated measures 2-way ANOVA | ||||||||
---|---|---|---|---|---|---|---|---|---|
Week 4 | Week 8 | Week 12 | Group | Time | Interaction | ||||
Mean | SD | Mean | SD | Mean | SD | ||||
Body weight, kg | |||||||||
Placebo | 0.31 | 0.72 | 0.52 | 0.93 | 0.65 | 0.86 | 0.009 | 0.037 | 0.583 |
CLE | −0.18* | 1.08 | −0.04* | 1.18 | −0.03* | 1.49 | |||
BMI, kg/m2 | |||||||||
Placebo | 0.12 | 0.28 | 0.20 | 0.38 | 0.26 | 0.33 | 0.007 | 0.023 | 0.520 |
CLE | −0.08* | 0.41 | −0.02* | 0.46 | −0.02* | 0.57 |
BMI body mass index
aValues represent the means and standard deviations for n = 40 (placebo group) or n = 39 (CLE group). *p < 0.05: Significant difference from the placebo group assessed by repeated measures two-way ANOVA, followed by the two-tailed unpaired Student’s t test when variance was homogeneous or the Aspin-Welch t test when variance was heterogeneous